[HTML][HTML] Management of rheumatoid arthritis: an overview

AF Radu, SG Bungau - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …

Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis

SC Manolagas - Endocrine reviews, 2000 - academic.oup.com
The adult skeleton regenerates by temporary cellular structures that comprise teams of
juxtaposed osteoclasts and osteoblasts and replace periodically old bone with new. A …

[HTML][HTML] Graphical tools for network meta-analysis in STATA

A Chaimani, JPT Higgins, D Mavridis, P Spyridonos… - PloS one, 2013 - journals.plos.org
Network meta-analysis synthesizes direct and indirect evidence in a network of trials that
compare multiple interventions and has the potential to rank the competing treatments …

Adverse effects of biologics: a network meta‐analysis and Cochrane overview

JA Singh, GA Wells, R Christensen… - Cochrane database …, 2011 - cochranelibrary.com
Background Biologics are used for the treatment of rheumatoid arthritis and many other
conditions. While the efficacy of biologics has been established, there is uncertainty …

Emerging cell and cytokine targets in rheumatoid arthritis

GR Burmester, E Feist, T Dörner - Nature Reviews Rheumatology, 2014 - nature.com
Despite major progress in the treatment of rheumatoid arthritis (RA), strong unmet medical
need remains, as only a minor proportion of patients reach sustained clinical remission. New …

Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease

BN Weber, JT Giles, KP Liao - Nature Reviews Rheumatology, 2023 - nature.com
The association between chronic inflammation and increased risk of cardiovascular disease
in rheumatoid arthritis (RA) is well established. In the general population, inflammation is an …

The role of cytokines in the pathogenesis of rheumatoid arthritis–Practical and potential application of cytokines as biomarkers and targets of personalized therapy

E Brzustewicz, E Bryl - Cytokine, 2015 - Elsevier
Rheumatoid arthritis (RA), as a common chronic disease leading to severe disability,
requires early diagnosis and introduction of proper treatment. Deregulation in the cytokine …

Salivary cytokines as biomarkers of periodontal diseases

KM Jaedicke, PM Preshaw, JJ Taylor - Periodontology 2000, 2016 - Wiley Online Library
Research into biomarkers of periodontitis is driven by mainly three targets: to identify 'at
risk'patients before periodontal tissue destruction occurs; to determine disease activity and …

Systemic safety of bevacizumab versus ranibizumab for neovascular age‐related macular degeneration

L Moja, E Lucenteforte, KH Kwag… - Cochrane Database …, 2014 - cochranelibrary.com
Background Neovascular age‐related macular degeneration (AMD) is the leading cause of
legal blindness in elderly populations of industrialised countries. Bevacizumab (Avastin®) …

Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care …

A Souto, JR Maneiro, JJ Gomez-Reino - Rheumatology, 2016 - academic.oup.com
Objectives. To assess the proportion of RA patients who discontinued biologics in world
registries and health care databases and to identify causes and predictors of …